Does the media favor AMN or CCRN?

In the previous week, AMN Healthcare Services had 11 more articles in the media than Cross Country Healthcare. MarketBeat recorded 14 mentions for AMN Healthcare Services and 3 mentions for Cross Country Healthcare. Cross Country Healthcare's average media sentiment score of 0.96 beat AMN Healthcare Services' score of 0.51 indicating that Cross Country Healthcare is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment AMN Healthcare Services 2 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Cross Country Healthcare 0 Very Positive mention(s) 2 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media favor DGX or CCRN?

In the previous week, Quest Diagnostics had 3 more articles in the media than Cross Country Healthcare. MarketBeat recorded 6 mentions for Quest Diagnostics and 3 mentions for Cross Country Healthcare. Quest Diagnostics' average media sentiment score of 1.17 beat Cross Country Healthcare's score of 0.96 indicating that Quest Diagnostics is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Quest Diagnostics 4 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Cross Country Healthcare 0 Very Positive mention(s) 2 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media favor LH or CCRN?

In the previous week, Labcorp had 11 more articles in the media than Cross Country Healthcare. MarketBeat recorded 14 mentions for Labcorp and 3 mentions for Cross Country Healthcare. Cross Country Healthcare's average media sentiment score of 0.96 beat Labcorp's score of 0.83 indicating that Cross Country Healthcare is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Labcorp 7 Very Positive mention(s) 2 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Cross Country Healthcare 0 Very Positive mention(s) 2 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media refer more to CCRN or DVA?

In the previous week, DaVita had 3 more articles in the media than Cross Country Healthcare. MarketBeat recorded 6 mentions for DaVita and 3 mentions for Cross Country Healthcare. Cross Country Healthcare's average media sentiment score of 0.96 beat DaVita's score of 0.27 indicating that Cross Country Healthcare is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Cross Country Healthcare 0 Very Positive mention(s) 2 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive DaVita 3 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Does the media prefer CCRN or CHE?

In the previous week, Chemed had 3 more articles in the media than Cross Country Healthcare. MarketBeat recorded 6 mentions for Chemed and 3 mentions for Cross Country Healthcare. Cross Country Healthcare's average media sentiment score of 0.96 beat Chemed's score of 0.59 indicating that Cross Country Healthcare is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Cross Country Healthcare 0 Very Positive mention(s) 2 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Chemed 2 Very Positive mention(s) 1 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Cross Country Healthcare (CCRN) Competitors

$13.22 +0.01 (+0.08%)

Closing price 07/10/2026 04:00 PM Eastern

Extended Trading

$13.22 -0.01 (-0.04%)

As of 07/10/2026 04:10 PM Eastern

Compare

CCRN vs. AMN, DGX, LH, DVA, and CHE

Should you buy Cross Country Healthcare stock or one of its competitors? MarketBeat compares Cross Country Healthcare with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Cross Country Healthcare include AMN Healthcare Services (AMN), Quest Diagnostics (DGX), Labcorp (LH), DaVita (DVA), and Chemed (CHE). These companies are all part of the "health care services" industry.

How does Cross Country Healthcare compare to AMN Healthcare Services?

AMN Healthcare Services (NYSE:AMN) and Cross Country Healthcare (NASDAQ:CCRN) are both small-cap health care services companies, but which is the better stock? We will contrast the two companies based on the strength of their media sentiment, institutional ownership, analyst recommendations, risk, profitability, valuation, earnings and dividends.

Cross Country Healthcare has lower revenue, but higher earnings than AMN Healthcare Services. AMN Healthcare Services is trading at a lower price-to-earnings ratio than Cross Country Healthcare, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
AMN Healthcare Services	$2.73B	0.46	-$95.70M	-$0.87	N/A
Cross Country Healthcare	$1.05B	0.41	-$94.85M	-$3.05	N/A

AMN Healthcare Services presently has a consensus price target of $27.00, indicating a potential downside of 16.82%. Cross Country Healthcare has a consensus price target of $12.05, indicating a potential downside of 8.85%. Given Cross Country Healthcare's higher probable upside, analysts plainly believe Cross Country Healthcare is more favorable than AMN Healthcare Services.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
AMN Healthcare Services	2 Sell rating(s)	3 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.22
Cross Country Healthcare	1 Sell rating(s)	9 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.90

AMN Healthcare Services has a net margin of -0.95% compared to Cross Country Healthcare's net margin of -9.84%. AMN Healthcare Services' return on equity of 18.01% beat Cross Country Healthcare's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
AMN Healthcare Services	-0.95%	18.01%	5.19%
Cross Country Healthcare	-9.84%	-0.74%	-0.54%

AMN Healthcare Services has a beta of 0.41, meaning that its stock price is 59% less volatile than the broader market. Comparatively, Cross Country Healthcare has a beta of 0.45, meaning that its stock price is 55% less volatile than the broader market.

99.2% of AMN Healthcare Services shares are owned by institutional investors. Comparatively, 96.0% of Cross Country Healthcare shares are owned by institutional investors. 1.1% of AMN Healthcare Services shares are owned by company insiders. Comparatively, 6.3% of Cross Country Healthcare shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

In the previous week, AMN Healthcare Services had 11 more articles in the media than Cross Country Healthcare. MarketBeat recorded 14 mentions for AMN Healthcare Services and 3 mentions for Cross Country Healthcare. Cross Country Healthcare's average media sentiment score of 0.96 beat AMN Healthcare Services' score of 0.51 indicating that Cross Country Healthcare is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
AMN Healthcare Services	2 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Cross Country Healthcare	0 Very Positive mention(s)	2 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Summary

AMN Healthcare Services beats Cross Country Healthcare on 10 of the 16 factors compared between the two stocks.

How does Cross Country Healthcare compare to Quest Diagnostics?

Quest Diagnostics (NYSE:DGX) and Cross Country Healthcare (NASDAQ:CCRN) are both health care services companies, but which is the better business? We will contrast the two companies based on the strength of their institutional ownership, risk, analyst recommendations, profitability, media sentiment, dividends, earnings and valuation.

Quest Diagnostics has a net margin of 9.07% compared to Cross Country Healthcare's net margin of -9.84%. Quest Diagnostics' return on equity of 15.60% beat Cross Country Healthcare's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Quest Diagnostics	9.07%	15.60%	7.06%
Cross Country Healthcare	-9.84%	-0.74%	-0.54%

In the previous week, Quest Diagnostics had 3 more articles in the media than Cross Country Healthcare. MarketBeat recorded 6 mentions for Quest Diagnostics and 3 mentions for Cross Country Healthcare. Quest Diagnostics' average media sentiment score of 1.17 beat Cross Country Healthcare's score of 0.96 indicating that Quest Diagnostics is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Quest Diagnostics	4 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Cross Country Healthcare	0 Very Positive mention(s)	2 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

88.1% of Quest Diagnostics shares are owned by institutional investors. Comparatively, 96.0% of Cross Country Healthcare shares are owned by institutional investors. 0.9% of Quest Diagnostics shares are owned by insiders. Comparatively, 6.3% of Cross Country Healthcare shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

Quest Diagnostics currently has a consensus price target of $216.58, indicating a potential upside of 4.33%. Cross Country Healthcare has a consensus price target of $12.05, indicating a potential downside of 8.85%. Given Quest Diagnostics' stronger consensus rating and higher possible upside, research analysts clearly believe Quest Diagnostics is more favorable than Cross Country Healthcare.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Quest Diagnostics	0 Sell rating(s)	7 Hold rating(s)	7 Buy rating(s)	0 Strong Buy rating(s)	2.50
Cross Country Healthcare	1 Sell rating(s)	9 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.90

Quest Diagnostics has a beta of 0.58, meaning that its share price is 42% less volatile than the broader market. Comparatively, Cross Country Healthcare has a beta of 0.45, meaning that its share price is 55% less volatile than the broader market.

Quest Diagnostics has higher revenue and earnings than Cross Country Healthcare. Cross Country Healthcare is trading at a lower price-to-earnings ratio than Quest Diagnostics, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Quest Diagnostics	$11.04B	2.08	$992M	$9.05	22.94
Cross Country Healthcare	$1.05B	0.41	-$94.85M	-$3.05	N/A

Summary

Quest Diagnostics beats Cross Country Healthcare on 14 of the 16 factors compared between the two stocks.

How does Cross Country Healthcare compare to Labcorp?

Labcorp (NYSE:LH) and Cross Country Healthcare (NASDAQ:CCRN) are both health care services companies, but which is the superior investment? We will contrast the two businesses based on the strength of their media sentiment, institutional ownership, risk, dividends, analyst recommendations, profitability, earnings and valuation.

Labcorp presently has a consensus target price of $313.33, indicating a potential upside of 13.20%. Cross Country Healthcare has a consensus target price of $12.05, indicating a potential downside of 8.85%. Given Labcorp's stronger consensus rating and higher probable upside, analysts plainly believe Labcorp is more favorable than Cross Country Healthcare.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Labcorp	0 Sell rating(s)	2 Hold rating(s)	8 Buy rating(s)	0 Strong Buy rating(s)	2.80
Cross Country Healthcare	1 Sell rating(s)	9 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.90

Labcorp has a net margin of 6.66% compared to Cross Country Healthcare's net margin of -9.84%. Labcorp's return on equity of 16.29% beat Cross Country Healthcare's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Labcorp	6.66%	16.29%	7.62%
Cross Country Healthcare	-9.84%	-0.74%	-0.54%

In the previous week, Labcorp had 11 more articles in the media than Cross Country Healthcare. MarketBeat recorded 14 mentions for Labcorp and 3 mentions for Cross Country Healthcare. Cross Country Healthcare's average media sentiment score of 0.96 beat Labcorp's score of 0.83 indicating that Cross Country Healthcare is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Labcorp	7 Very Positive mention(s)	2 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Cross Country Healthcare	0 Very Positive mention(s)	2 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Labcorp has higher revenue and earnings than Cross Country Healthcare. Cross Country Healthcare is trading at a lower price-to-earnings ratio than Labcorp, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Labcorp	$14.14B	1.60	$876.50M	$11.29	24.52
Cross Country Healthcare	$1.05B	0.41	-$94.85M	-$3.05	N/A

Labcorp has a beta of 0.89, meaning that its share price is 11% less volatile than the broader market. Comparatively, Cross Country Healthcare has a beta of 0.45, meaning that its share price is 55% less volatile than the broader market.

95.9% of Labcorp shares are owned by institutional investors. Comparatively, 96.0% of Cross Country Healthcare shares are owned by institutional investors. 0.8% of Labcorp shares are owned by company insiders. Comparatively, 6.3% of Cross Country Healthcare shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

Summary

Labcorp beats Cross Country Healthcare on 13 of the 16 factors compared between the two stocks.

How does Cross Country Healthcare compare to DaVita?

Cross Country Healthcare (NASDAQ:CCRN) and DaVita (NYSE:DVA) are both health care services companies, but which is the superior stock? We will contrast the two companies based on the strength of their earnings, risk, analyst recommendations, dividends, valuation, profitability, media sentiment and institutional ownership.

Cross Country Healthcare has a beta of 0.45, suggesting that its share price is 55% less volatile than the broader market. Comparatively, DaVita has a beta of 0.88, suggesting that its share price is 12% less volatile than the broader market.

In the previous week, DaVita had 3 more articles in the media than Cross Country Healthcare. MarketBeat recorded 6 mentions for DaVita and 3 mentions for Cross Country Healthcare. Cross Country Healthcare's average media sentiment score of 0.96 beat DaVita's score of 0.27 indicating that Cross Country Healthcare is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Cross Country Healthcare	0 Very Positive mention(s)	2 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
DaVita	3 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

96.0% of Cross Country Healthcare shares are held by institutional investors. Comparatively, 90.1% of DaVita shares are held by institutional investors. 6.3% of Cross Country Healthcare shares are held by company insiders. Comparatively, 1.5% of DaVita shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

Cross Country Healthcare presently has a consensus price target of $12.05, indicating a potential downside of 8.85%. DaVita has a consensus price target of $209.00, indicating a potential downside of 10.11%. Given Cross Country Healthcare's higher probable upside, equities research analysts clearly believe Cross Country Healthcare is more favorable than DaVita.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Cross Country Healthcare	1 Sell rating(s)	9 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.90
DaVita	1 Sell rating(s)	5 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.13

DaVita has higher revenue and earnings than Cross Country Healthcare. Cross Country Healthcare is trading at a lower price-to-earnings ratio than DaVita, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Cross Country Healthcare	$1.05B	0.41	-$94.85M	-$3.05	N/A
DaVita	$13.64B	1.09	$746.80M	$10.78	21.57

DaVita has a net margin of 5.65% compared to Cross Country Healthcare's net margin of -9.84%. Cross Country Healthcare's return on equity of -0.74% beat DaVita's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Cross Country Healthcare	-9.84%	-0.74%	-0.54%
DaVita	5.65%	-270.37%	4.87%

Summary

DaVita beats Cross Country Healthcare on 11 of the 16 factors compared between the two stocks.

How does Cross Country Healthcare compare to Chemed?

Cross Country Healthcare (NASDAQ:CCRN) and Chemed (NYSE:CHE) are both health care services companies, but which is the superior stock? We will compare the two companies based on the strength of their profitability, risk, analyst recommendations, dividends, media sentiment, earnings, institutional ownership and valuation.

Cross Country Healthcare has a beta of 0.45, suggesting that its share price is 55% less volatile than the broader market. Comparatively, Chemed has a beta of 0.52, suggesting that its share price is 48% less volatile than the broader market.

Chemed has higher revenue and earnings than Cross Country Healthcare. Cross Country Healthcare is trading at a lower price-to-earnings ratio than Chemed, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Cross Country Healthcare	$1.05B	0.41	-$94.85M	-$3.05	N/A
Chemed	$2.53B	2.56	$265.24M	$18.35	26.58

Cross Country Healthcare presently has a consensus price target of $12.05, indicating a potential downside of 8.85%. Chemed has a consensus price target of $480.25, indicating a potential downside of 1.54%. Given Chemed's stronger consensus rating and higher possible upside, analysts clearly believe Chemed is more favorable than Cross Country Healthcare.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Cross Country Healthcare	1 Sell rating(s)	9 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.90
Chemed	0 Sell rating(s)	5 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.17

Chemed has a net margin of 10.23% compared to Cross Country Healthcare's net margin of -9.84%. Chemed's return on equity of 27.18% beat Cross Country Healthcare's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Cross Country Healthcare	-9.84%	-0.74%	-0.54%
Chemed	10.23%	27.18%	17.38%

In the previous week, Chemed had 3 more articles in the media than Cross Country Healthcare. MarketBeat recorded 6 mentions for Chemed and 3 mentions for Cross Country Healthcare. Cross Country Healthcare's average media sentiment score of 0.96 beat Chemed's score of 0.59 indicating that Cross Country Healthcare is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Cross Country Healthcare	0 Very Positive mention(s)	2 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Chemed	2 Very Positive mention(s)	1 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

96.0% of Cross Country Healthcare shares are owned by institutional investors. Comparatively, 95.9% of Chemed shares are owned by institutional investors. 6.3% of Cross Country Healthcare shares are owned by company insiders. Comparatively, 3.3% of Chemed shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

Summary

Chemed beats Cross Country Healthcare on 13 of the 16 factors compared between the two stocks.

Get Cross Country Healthcare News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding CCRN and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

CCRN vs. The Competition

Export

Metric	Cross Country Healthcare	Staffing Industry	Business Sector	NASDAQ Exchange
Market Cap	$427.09M	$1.23B	$6.91B	$12.66B
Dividend Yield	N/A	3.60%	3.12%	8.00%
P/E Ratio	-4.33	12.13	29.27	24.53
Price / Sales	0.41	2.35	347.52	96.17
Price / Cash	25.06	12.90	23.47	60.03
Price / Book	1.34	3.83	5.74	6.38
Net Income	-$94.85M	$9.03M	$204.80M	$331.87M
7 Day Performance	0.15%	0.08%	-1.41%	0.37%
1 Month Performance	0.38%	6.11%	1.46%	0.59%
1 Year Performance	9.53%	-7.94%	16.36%	22.26%

Cross Country Healthcare Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
CCRN Cross Country Healthcare	1.9842 of 5 stars	$13.22 +0.1%	$12.05 -8.9%	+9.5%	$427.09M	$1.05B	N/A	6,784
AMN AMN Healthcare Services	1.7969 of 5 stars	$32.55 -0.6%	$27.00 -17.1%	+53.3%	$1.27B	$2.73B	N/A	2,664	Positive News Analyst Revision
DGX Quest Diagnostics	4.412 of 5 stars	$212.26 +1.1%	$216.58 +2.0%	+23.6%	$23.23B	$11.04B	23.45	57,000	Positive News Analyst Upgrade
LH Labcorp	4.4683 of 5 stars	$279.60 +3.0%	$308.00 +10.2%	+11.1%	$22.26B	$13.95B	24.77	71,000	News Coverage Dividend Announcement
DVA DaVita	3.5668 of 5 stars	$219.37 +1.1%	$199.17 -9.2%	+63.2%	$13.93B	$13.84B	20.35	78,000	Analyst Forecast

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:CCRN) was last updated on 7/12/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Cross Country Healthcare (CCRN) Competitors

CCRN vs. AMN, DGX, LH, DVA, and CHE

How does Cross Country Healthcare compare to AMN Healthcare Services?

Summary

How does Cross Country Healthcare compare to Quest Diagnostics?

Summary

How does Cross Country Healthcare compare to Labcorp?

Summary

How does Cross Country Healthcare compare to DaVita?

Summary

How does Cross Country Healthcare compare to Chemed?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

CCRN vs. The Competition

Cross Country Healthcare Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Cross Country Healthcare (CCRN) Competitors

CCRN vs. AMN, DGX, LH, DVA, and CHE

How does Cross Country Healthcare compare to AMN Healthcare Services?

Which has stronger valuation and earnings, AMN or CCRN?

Do analysts prefer AMN or CCRN?

Is AMN or CCRN more profitable?

Which has more volatility & risk, AMN or CCRN?

Do insiders and institutionals believe in AMN or CCRN?

Does the media favor AMN or CCRN?

Summary

How does Cross Country Healthcare compare to Quest Diagnostics?

Is DGX or CCRN more profitable?

Does the media favor DGX or CCRN?

Do institutionals & insiders believe in DGX or CCRN?

Do analysts prefer DGX or CCRN?

Which has more volatility and risk, DGX or CCRN?

Which has better earnings & valuation, DGX or CCRN?

Summary

How does Cross Country Healthcare compare to Labcorp?

Do analysts rate LH or CCRN?

Is LH or CCRN more profitable?

Does the media favor LH or CCRN?

Which has higher earnings and valuation, LH or CCRN?

Which has more risk & volatility, LH or CCRN?

Do institutionals and insiders believe in LH or CCRN?

Summary

How does Cross Country Healthcare compare to DaVita?

Which has more volatility and risk, CCRN or DVA?

Does the media refer more to CCRN or DVA?

Do insiders and institutionals have more ownership in CCRN or DVA?

Do analysts recommend CCRN or DVA?

Which has stronger valuation & earnings, CCRN or DVA?

Is CCRN or DVA more profitable?

Summary

How does Cross Country Healthcare compare to Chemed?

Which has more volatility and risk, CCRN or CHE?

Which has higher valuation & earnings, CCRN or CHE?

Do analysts rate CCRN or CHE?

Is CCRN or CHE more profitable?

Does the media prefer CCRN or CHE?

Do institutionals & insiders have more ownership in CCRN or CHE?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

CCRN vs. The Competition

Cross Country Healthcare Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools